| Date | Title | Description |
| 06.05.2025 | AI Meets Value-Based Care: Cleerly and Cardiac Care Alliance Join Forces | What You Should Know:
– Cleerly, a leader in cardiovascular imaging, and Cardiac Care Alliance, a prominent figure in value-based cardiovascular care solutions, today announced a strategic partnership aimed at significantly enhancing cardio... |
| 06.12.2024 | Cleerly's $106M Funding: A Leap Towards Revolutionizing Cardiac Care | In the world of healthcare, innovation is the lifeblood that keeps the system beating. Cleerly, a Denver-based company, has just secured a hefty $106 million in funding. This infusion of capital, led by Insight Partners and joined by Batter... |
| 06.12.2024 | Cleerly scores $106M for heart disease diagnosis tools | Photo: REB Images/Getty Images
Cardiovascular imaging company Cleerly announced it raised $106 million in a Series C funding round.
The round was led by Insight Partners and Battery Ventures with participation from pre-existing investors.
W... |
| 06.12.2024 | Cleerly: Advanced Cardiovascular Imaging Company Raises $106 Million (Series C Extension) | Cleerly – a leader in advanced cardiovascular imaging – announced the closing of its Series C extension funding round, raising a total of $106 million. This funding round was led by global software investor Insight Partners and joined by Ba... |
| 05.12.2024 | Bitcoin Breaks the $100,000 Barrier: A New Era for Cryptocurrency | Bitcoin has crossed a monumental threshold. Late on a Wednesday night, the price surged past $100,000 for the first time. This milestone isn’t just a number; it’s a signal. A signal that the cryptocurrency is maturing. A signal that it’s be... |
| 05.12.2024 | Cleerly collects $106M for its coronary artery scanning AI | Cleerly has claimed an additional $106 million in funding to boost the reach of its artificial intelligence programs for cardiovascular imaging as it aims to capitalize on recent gains in reimbursements and Medicare coverage.
The nine-figur... |
| 05.12.2024 | Cleerly привлекла $106 млн инвестиций на развитие AI-диагностики сердечных заболеваний | Сердечно-сосудистые заболевания остаются частой причиной смерти, причем многие люди, перенесшие инфаркт, могли даже не подозревать о наличии болезни. Стартап Cleerly разрабатывает решение этой проблемы с помощью кардиологической визуализаци... |
| 05.12.2024 | Cleerly Secures $106M to Advance AI-Powered Cardiac Care | What You Should Know:
– Cleerly, a pioneer in advanced cardiovascular imaging, has announced the successful closure of its Series C extension funding round, raising a total of $106M led by Insight Partners, with participation from Battery V... |
| 04.12.2024 | Cleerly Raises $106M in Funding | Cleerly, a Denver, CO-based company which specializes in advanced cardiovascular imaging, raised $106M in funding.
The round was led by Insight Partners and joined by Battery Ventures with participation from pre-existing investors.
The comp... |
| 04.09.2024 | Viz.ai and Cleerly Partner for AI Heart Disease Evaluation | What You Should Know:
– Viz.ai, a leader in AI-powered disease detection, announced a partnership with Cleerly, a company specializing in AI-driven diagnosis of heart disease.
– This collaboration aims to improve and expedite care coordinat... |
| 07.02.2024 | 44 startups to bet your career on in 2024 | Premium Startups 44 startups to bet your career on in 2024
Ben Bergman, Julie Bort, Vishal Persaud, Darius Rafieyan, Leena Rao, Melia Russell, Samantha Stokes, and Rebecca Torrence
2024-02-07T10:00:01Z
Share icon An curved arrow pointing ri... |
| 18.12.2023 | 25 healthcare startups that are set to take off in 2024, according to top VCs | Healthcare 25 healthcare startups that are set to take off in 2024, according to top VCs
Rebecca Torrence, Shelby Livingston, and Blake Dodge
2023-12-18T10:55:02Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
... |
| 11.11.2023 | Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 | – Data from Randomized Control Trial Will Advance Evidence for Evaluation and Treatment of Heart Disease by Studying Actual Disease: Atherosclerosis –
ANN ARBOR, Mich., Nov. 11, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) announced par... |
| 11.11.2023 | Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 | DENVER--(BUSINESS WIRE)--Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the TRANSFORM trial at the American Heart Association’s (AHA) 2023 Scientific Sessions. TRANSFORM is ... |
| 06.03.2023 | Cleerly to Present New Clinical Evidence on AI-Enabled CCTA at ACC.23/WCC | Research shows accuracy and effectiveness of Cleerly’s personalized evaluation of heart disease
Cleerly, the company creating a new standard of care for heart disease, announced it will be presenting a number of new research studies at the ... |
| 14.02.2023 | Cardiac AI-Pioneer Cleerly Partners with ClearDATA to Protect Patient Data | Cleerly revolutionizes precision healthcare by leveraging secure patient imaging for AI interpretation
ClearDATA, healthcare’s most comprehensive managed cloud, compliance and cyber defense provider, announced a partnership with Cleerly, th... |
| 14.02.2023 | Cleerly partners with ClearDATA to keep patient health data secure | Cleerly uses AI to identify the features of plaques that may cause heart attacks
Cybersecurity is important to every industry, but none more so than in healthcare, which is some of the most personal information you can get on a person. Yet,... |
| 21.11.2022 | Digital health news, funding round up in the prior week; November 21, 2022 | DispatchHealth raised $330M; Sondermind bought True Brain; Elizabeth Holmes gets 11 years in prison
Top Health News
Highmark Health, Google Cloud, and League unveiled their collaboration on an interoperable, digital health platform that mak... |
| 17.11.2022 | Cleerly partners with Heartbeat Health in new heart disease detection program | NEW YORK--(BUSINESS WIRE)--Cleerly, the company creating a new standard of care for heart disease, and Heartbeat Health, the nation's largest virtual-first cardiovascular company, today announced a partnership to use precision heart health ... |
| 26.07.2022 | Cleerly Raises $192M for AI-Driven Precision Heart Health Platform | What You Should Know:
– Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192M
– This new funding, led by led by funds and accounts advised by T. Rowe Price A... |
| 26.07.2022 | Heart attack prediction startup Cleerly scores $192M and more digital health fundings | Photo: Kwanchai Lerttanapunyaporn/EyeEm/Getty Images |
| 25.07.2022 | AI-based heart health platform Cleerly raises $192M | The company recently released a new product to compare scans to track disease progression
Despite the fact that heart disease has long been the number one cause of death in the U.S., heart doctors have never actually measured heart disease ... |
| 25.07.2022 | CalPERS gives an early indication of what 2022 has in store for pension funds | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Kevin Kelleher here, filling in this week while Jessica is on vacation.
Paid Content How KPMG is ... |
| 25.07.2022 | Cleerly Closes $192M Series C Funding Round | Cleerly, a NYC-based heart disease care company, closed a Series C financing round of $192m.
This round, which brought the total raised by the health care company to $248m, was led by funds and accounts advised by T. Rowe Price Associates, ... |
| 22.02.2022 | Study: AI-enabled coronary CT angiography as good if not better than Echo, other tests to identify heart disease | A new study found that a non-invasive, AI enabled Coronary Computer Tomography Angiography effectively identified stenosis equally well or better than the conventional gold standard of Echo Cardiogram and other more invasive methods for det... |
| 01.10.2021 | StartUPDATES: New developments for healthcare startups | HealthMine‘s EVP of Consulting and Professional Services, Melissa Smith, recently led a presentation sharing how health plans can shift their member engagement strategy to effectively reach members post-pandemic. Check it out to learn how d... |
| 02.07.2021 | Cleerly founder and CEO Jim Min on VatorNews podcast | The platform uses AI and machine learning to identify risk factors for heart attacks
Vator · Interview with Cleerly founder and CEO Jim Min
Steven Loeb and Bambi Francisco interview Jim Min, founder and CEO of Cleerly, a company that uses a... |
| 28.06.2021 | Cleerly raises $43 million to tackle heart attacks | New York-based Cleerly Cleerly
Founded: 2017
Headquarters: New York, NY, US
Total Funding: $57.48M
See full company profile "> is now live following a $43 million Series B funding round led by Vensana Capital with participation from... |
| 22.06.2021 | The battle forming in the European fintech scene | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content The true value of equity compensation From Personal Capital
It’s no secret: Venture ... |
| 22.06.2021 | The battle forming in the European fintech scene | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
It’s no secret: Venture capitalists have grown bullish about Europe.
In the first quarter of the ... |
| 22.06.2021 | Daily funding roundup - June 21st, 2021 | Songtradr raised $50M; Securitize landed $48M; Cleerly secured $43M; DataRails picks up $25M
Songtradr: Songtradr is a L.A.-based music licensing marketplace. Songtradr has raised $50 million in Series D funding from Regal, Aware Super, Per... |
| 21.06.2021 | Cleerly, a startup using AI to diagnose coronary artery disease, raises $43M | The company, which launched on Monday, also got three new board members
Heart disease has long been the number one cause of death in the U.S. and some of the stats are startling: an American will have a heart attack approximately every 40 s... |
| 21.06.2021 | Cleerly launches with $43M to tackle heart attacks with AI-powered imaging
Fierce Pharma Webinar | Using artificial intelligence-powered imaging tech developed at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has launched to help provide a digital-first approach to preventing heart attacks.
“Advanced imaging has been... |
| 21.06.2021 | Cleerly : Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease | Cleerly, the company creating a new standard of care for heart disease, launched today with $43 million in Series B funding and unveiled its first-of-its-kind digital care pathway solution for heart attack prevention. The financing, which w... |
| 21.06.2021 | Cleerly launches with $43M in funding to revolutionize care for leading cause of death – Heart Disease | Heart disease is the leading cause of death among people of most racial and ethnic groups in the United States. According to the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds in the United States from ca... |
| 21.06.2021 | Cleerly Launches with $43M for Digital Care Pathway Solution for Heart Attack Prevention | What You Should Know:
– Cleerly, a New York City-based company launched today with $43M in Series B funding and unveiled its first-of-its-kind digital care pathway solution for heart attack prevention. The Series B funding, which was led by... |
| 21.06.2021 | Cleerly Raises $43M in Series B Funding | Cleerly, a NYC-based company creating a new standard of care for heart disease, launched with $43m in Series B funding.
The round, which brings Cleerly’s total funding to $54m, was led by Vensana Capital with participation from LRVHealth, N... |
| - | Медицинский стартап Cleerly Coronary разрабатывает ИИ-инструмент для анализа снимков сердца | Image сredit: cleerlyhealth.com
0 Обсудить
29 просмотров
Медицинский стартап из Нью-Йорка Cleerly Coronary разрабатывает ИИ-инструмент для анализа изображений сердца, полученных в результате коронарной КТА. 23 июня компания объявила о привл... |
| - | Study: AI-enabled coronary CT angiography as good if not better than invasive angiography to identify heart disease | A new study found that a non-invasive, AI enabled Coronary Computer Tomography Angiography effectively identified stenosis equally well or better than the conventional gold standard of invasive angiography for detecting heart disease.
Cleer... |
| - | StartUPDATES: New developments for healthcare startups | HealthMine‘s EVP of Consulting and Professional Services, Melissa Smith, recently led a presentation sharing how health plans can shift their member engagement strategy to effectively reach members post-pandemic. Check it out to learn how d... |
| - | Cleerly | “Cleerly determines your risk of heart attack by performing a non-invasive whole heart assessment to identify, characterize, and quantify plaque buildup.” |
